Matthew G. Kaag

Matthew G. Kaag, MD, is an Associate Professor in the Department of Urology and Department of Surgery at Penn State University. His research focuses on bladder cancer, transitional cell carcinoma, and urological oncology, with a particular emphasis on muscle-invasive bladder cancer, patient perspectives, and clinical management strategies. He has contributed to studies on diagnosis stage optimization, immunotherapy in localized urothelial cancer, and complications arising from prostate biopsy procedures.

• Primary Affiliation: Penn State University (Department of Urology and Department of Surgery)

Dr. Kaag’s work aligns with global health priorities, particularly in cancer control and treatment. His recent publications highlight trends in bladder cancer research, urothelial cancer, and healthcare access disparities. Notable collaborations include studies on durvalumab-based immunotherapy (Journal for ImmunoTherapy of Cancer, 2023) and systemic analysis of bleeding complications post-biopsy (Urology Practice, 2023).